Pharmaceutical Company Allegedly Involved In Kickback Scheme For Opioid Medication
Updated on
Case Overview
This case involves a pharmaceutical company allegedly involved in a widespread kickback scheme in which they were paying physicians to prescribe an opioid pain medication. It was suggested that the company fraudulently marketed this drug for off-label use and employed improper warning practices when promoting the drug. An expert was sought to opine on the research related to the speaker programs many big pharma companies have implemented, along with the potential relationship between the drug’s promotion and kickback programs for physicians.
Subscribe to our newsletter
Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.
Sign up nowFind an expert witness near you
What State is your case in?
Subscribe to our newsletter
Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.